Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.18%453.76M | 6.50%445.68M | 2.59%428.59M | 6.24%1.69B | 1.97%430.59M | 2.99%423.35M | 7.53%418.49M | 13.39%417.77M | 9.36%1.59B | 6.58%422.26M |
| Cost of revenue | 0.60%324.38M | 0.59%322.43M | ||||||||
| Gross profit | 7.67%1.37B | 11.83%1.27B | ||||||||
| Operating expense | -6.88%336.33M | 5.64%309.58M | 2.50%294.75M | 0.48%849.67M | -4.50%307.51M | 30.96%361.19M | -20.36%293.05M | 19.29%287.55M | 30.71%845.63M | 1,097.90%321.98M |
| Staff costs | ---- | ---- | ---- | -11.12%310.1M | ---- | ---- | ---- | ---- | 28.23%348.92M | ---- |
| Depreciation and amortization | 6.08%51.83M | 5.88%49.41M | -3.70%48.19M | 5.92%194.08M | -1.93%48.51M | 7.48%48.86M | -1.31%46.67M | 22.00%50.04M | 22.53%183.23M | 25.29%49.46M |
| -Depreciation | 6.08%51.83M | 5.88%49.41M | -3.70%48.19M | 5.29%192.93M | -1.93%48.51M | 7.48%48.86M | -1.31%46.67M | 22.00%50.04M | 22.53%183.23M | 25.30%49.46M |
| -Amortization | ---- | ---- | ---- | 38,266.67%1.15M | ---- | ---- | ---- | ---- | -25.00%3K | ---- |
| Rent and land expenses | ---- | ---- | ---- | 74.60%32.18M | ---- | ---- | ---- | ---- | 51.04%18.43M | ---- |
| Other operating expenses | -8.97%284.6M | 5.62%260.24M | 2.01%247.14M | 5.90%315.17M | -4.66%259.83M | 33.28%312.66M | -27.11%246.38M | 16.69%242.27M | 38.44%297.62M | 168.59%272.52M |
| Total other operating income | -69.09%102K | --70K | -87.83%579K | -27.77%1.85M | --826K | -92.23%330K | ---- | -37.14%4.76M | 37.70%2.56M | ---- |
| Operating profit | 88.91%117.43M | 8.50%136.1M | 2.78%133.83M | 22.05%516.15M | 22.75%123.08M | -54.05%62.16M | 491.32%125.44M | 2.24%130.21M | -13.22%422.89M | -7.10%100.27M |
| Net non-operating interest income (expenses) | -142.50%-2.63M | 6.34%-5.85M | 4.17%-5.74M | 12.53%19.8M | -43.44%4.17M | 13.63%6.18M | -14.24%-6.24M | -29.70%-5.99M | 308.10%17.59M | 576.65%7.37M |
| Non-operating interest income | -69.95%3.61M | ---- | ---- | 9.54%43.82M | -26.23%10.13M | 5.29%12M | ---- | ---- | 316.71%40M | 547.03%13.73M |
| Non-operating interest expense | 6.95%6.23M | -6.34%5.85M | -4.17%5.74M | 7.19%24.02M | -6.30%5.96M | -2.31%5.83M | 14.24%6.24M | 29.70%5.99M | 24.14%22.41M | 73.42%6.36M |
| Net investment income | -67.12%3.44M | -22.70%8.67M | -16.77%10.47M | 363.44%11.22M | -9.89%25.66M | |||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -23.33%12.91M | 63.49%9.5M | -35.94%9.86M | 94.94%65.45M | 160.52%27.4M | 84.50%16.84M | -15.94%5.81M | 119.49%15.4M | 46.14%33.57M | 84.36%10.52M |
| Special income (charges) | -17.04%-75.25M | -392.96%-64.3M | ||||||||
| Less:Impairment of capital assets | ---- | ---- | ---- | -9.23%47.97M | ---- | ---- | ---- | ---- | 4,593.61%52.85M | ---- |
| Less:Other special charges | ---- | ---- | ---- | -170.00%-135K | ---- | ---- | ---- | ---- | 96.73%-50K | ---- |
| Less:Write off | ---- | ---- | ---- | 138.46%27.42M | ---- | ---- | ---- | ---- | -14.50%11.5M | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 49.94%127.72M | 5.70%143.19M | -2.79%146.63M | 20.84%526.13M | 30.88%154.65M | -43.15%85.18M | 284.47%135.47M | 14.12%150.84M | -15.83%435.41M | -7.35%118.16M |
| Income tax | -15.68%21.89M | 8.39%38.69M | -11.01%34.32M | -2.06%140.65M | -1.67%40.44M | -37.27%25.96M | 9.10%35.7M | 35.80%38.56M | 9.51%143.62M | 19.97%41.12M |
| Net income | 78.71%105.83M | 4.74%104.5M | 0.03%112.31M | -85.03%385.48M | 30.71%114.21M | -45.40%59.22M | -95.59%99.77M | -1.87%112.28M | 467.65%2.57B | -29.70%87.38M |
| Net income continuous operations | 78.71%105.83M | 4.74%104.5M | 0.03%112.31M | 32.11%385.48M | 48.25%114.21M | -45.40%59.22M | 3,863.97%99.77M | 8.18%112.28M | -24.43%291.79M | -17.39%77.04M |
| Net income discontinuous operations | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | 3,284.04%2.28B | -66.70%10.34M |
| Noncontrolling interests | -161.55%-317K | -118.34%-133K | -142.37%-680K | -55.98%2.65M | -107.81%-193K | -72.25%515K | -59.45%725K | 1,903.37%1.61M | 62.84%6.03M | 19.96%2.47M |
| Net income attributable to the company | 80.81%106.15M | 5.64%104.63M | 2.10%112.99M | -85.10%382.83M | 34.74%114.4M | -44.93%58.71M | -95.62%99.05M | -3.35%110.67M | 470.98%2.57B | -30.54%84.91M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 80.81%106.15M | 5.64%104.63M | 2.10%112.99M | -85.10%382.83M | 34.74%114.4M | -44.93%58.71M | -95.62%99.05M | -3.35%110.67M | 470.98%2.57B | -30.54%84.91M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 80.50%0.0574 | 5.60%0.0566 | 2.00%0.0611 | -85.15%0.2071 | 34.57%0.0619 | -44.98%0.0318 | -95.65%0.0536 | -3.85%0.0599 | 467.41%1.3947 | -30.93%0.046 |
| Diluted earnings per share | 81.07%0.0574 | 5.79%0.0566 | 2.00%0.0611 | -85.12%0.2071 | 35.15%0.0619 | -45.16%0.0317 | -95.65%0.0535 | -3.85%0.0599 | 466.69%1.3918 | -31.23%0.0458 |
| Dividend per share | 0 | 0 | 26.30%0.1042 | -33.09%0.0825 | 0 | 0 | 0 | -33.09%0.0825 | 13.54%0.1233 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.